Aminopeptides ameliorate long COVID symptoms in immunocompromised rheumatic patients through immune reconstitution
International Immunopharmacology · 2026-06 · 179 · 116630
DOI: 10.1016/j.intimp.2026.116630 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-06. Verfasst von Huijing Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medic…. Hauptthemen laut MEDLINE: Immunocompromised Host, Rheumatic Diseases, COVID-19, COVID-19 Drug Treatment. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Hebei Province Medical Science Research Key Project, Chinese Academy of Medical Sciences, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.
Abstract (Originalsprache)
OBJECTIVE To evaluate the effects of aminopeptide nutritional support on immune reconstitution and antiviral capacity in immunocompromised patients with rheumatic diseases. METHODS This single-center, retrospective cohort study included patients with rheumatic diseases and concomitant immunocompromised conditions who received treatments at the outpatient department of Peking Union Medical College Hospital between December 2021 and October 2024. Participants were divided into an experimental group (aminopeptide supplementation) and a control group according to whether they received aminopeptide treatment, with a treatment duration of 2-3 months. Data regarding SARS-CoV-2 virus infection, specific Long COVID symptoms, and outcomes were collected via questionnaire. TB lymphocyte subsets were recorded before and after treatment or at 3-6-month intervals. RESULTS A total of 171 patients with rheumatic diseases were enrolled, including 102 in the experimental group and 69 in the control group. Eighty-eight patients exhibited Long COVID symptoms, with fatigue being the most prevalent (67%). The experimental group showed a significantly higher rate of Long COVID symptom remission compared to the control group (64.2% vs. 22.9%), with a notable improvement in fatigue (68.3% vs. 27.8). Significant post-treatment increases were observed in peripheral blood CD3+ T cells and CD8+ T cells. Multivariate logistic regression analysis indicated that aminopeptide supplementation increased the rate of Long COVID symptom remission by 8.46-fold and the rate of fatigue improvement by 9.19-fold. CONCLUSION Supplementation with aminopeptides may improve nutritional status and enhance TB lymphocyte subsets levels in immunocompromised patients with rheumatic diseases, potentially contributing to better antiviral immunity and alleviation of Long COVID symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Rheumatology and Immunology,…
- Department of Rheumatism and Immunology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Zhejiang, China.
- Department of Liver Surgery, Peking Union Medical College Hospital, Beijing, China.
- Wake Forest University, China.
- Laboratory Animal Research Facility, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medica…
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Förderung
- Hebei Province Medical Science Research Key Project
- Chinese Academy of Medical Sciences
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Shi, H., Zhang, Y., Yao, Z., Song, W., Xu, X., Tang, X., Cui, L., Song, H., Shu, R., Wang, J., & You, X. (2026). Aminopeptides ameliorate long COVID symptoms in immunocompromised rheumatic patients through immune reconstitution. International Immunopharmacology, 179, 116630. https://doi.org/10.1016/j.intimp.2026.116630
Vancouver
Shi H, Zhang Y, Yao Z, Song W, Xu X, Tang X, et al. Aminopeptides ameliorate long COVID symptoms in immunocompromised rheumatic patients through immune reconstitution. International Immunopharmacology. 2026;179:116630. doi:10.1016/j.intimp.2026.116630
BibTeX
@article{Shi2026,
author = {Shi, Huijing and Zhang, Yan and Yao, Ziqi and Song, Wenqing and Xu, Xinjie and Tang, Xuan and Cui, Liufu and Song, Haicheng and Shu, Rong and Wang, Jierui and You, Xin},
title = {Aminopeptides ameliorate long COVID symptoms in immunocompromised rheumatic patients through immune reconstitution},
journal = {International Immunopharmacology},
year = {2026},
volume = {179},
pages = {116630},
doi = {10.1016/j.intimp.2026.116630}
}
EUVIMED